Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012
- PMID: 34533289
- PMCID: PMC8495271
- DOI: 10.1002/cam4.4193
Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012
Abstract
Background: The number of patients living after a cancer diagnosis is increasing, especially after thyroid cancer (TC). This study aims at evaluating both the risk of a second primary cancer (SPC) in TC patients and the risk of TC as a SPC.
Methods: We analyzed two population-based cohorts of individuals with TC or other neoplasms diagnosed between 1998 and 2012, in 28 Italian areas covered by population-based cancer registries. Standardized incidence ratios (SIRs) of SPC were stratified by sex, age, and time since first cancer.
Results: A total of 38,535 TC patients and 1,329,624 patients with other primary cancers were included. The overall SIR was 1.16 (95% CI: 1.12-1.21) for SPC in TC patients, though no increase was shown for people with follicular (1.06) and medullary (0.95) TC. SPC with significantly increased SIRs was bone/soft tissue (2.0), breast (1.2), prostate (1.4), kidney (2.2), and hemolymphopoietic (1.4) cancers. The overall SIR for TC as a SPC was 1.49 (95% CI: 1.42-1.55), similar for all TC subtypes, and it was significantly increased for people diagnosed with head and neck (2.1), colon-rectum (1.4), lung (1.8), melanoma (2.0), bone/soft tissue (2.8), breast (1.3), corpus uteri (1.4), prostate (1.5), kidney (3.2), central nervous system (2.3), and hemolymphopoietic (1.8) cancers.
Conclusions: The increased risk of TC after many other neoplasms and of few SPC after TC questions the best way to follow-up cancer patients, avoiding overdiagnosis and overtreatment for TC and, possibly, for other malignancies.
Keywords: Italy; cancer survivors; population-based cancer registries; relative risk; second primary cancer; thyroid cancer.
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have declared no competing interests.
Figures
References
-
- Bluethmann SM, Mariotto AB, Rowland JH, . Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev. 2016;25:1029‐1036. https://cebp.aacrjournals.org/content/25/7/1029.long - PMC - PubMed
-
- Dal Maso L, Panato C, Franceschi S, et al; for AIRTUM Working Group . The impact of overdiagnosis on thyroid cancer epidemic in Italy, 1998‐2012. Eur J Cancer. 2018;94:6‐15. - PubMed
-
- Buzzoni C, Crocetti E, Guzzinati S, et al; AIRTUM Working Group . Cancer incidence and mortality trends from 2003 to 2014 in Italy. Tumori J. 2019;105:121‐137 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
